China Health Technology Group Share Placement Lapses
China Health Technology Group (01069.HK): New share issuance under general authorization is invalidated.
China Health-Tech Group (01069.HK) announced on July 8th that the conditions under the placement agreement were not met before July 5th, 2024. Therefore, the placement agreement did not become unconditional and expired on July 5th, 2024. Pursuant to the placement agreement, all obligations and responsibilities of the counterparties in relation to the placement matter will be terminated, and except for any prior breach, no counterparty shall make any claim against any other party in respect of any matter arising out of or in connection with the placement matter.
China Health Technology Hires Auditor
China Health Technology Group Limited (01069.HK) appoints Zhongzhi Xin (Hong Kong) as its new auditor.
China Health Technology Group (01069.HK) announced on June 14 that the board of directors has appointed Zhongzhi Xing (Hong Kong) Certified Public Accountants Limited ("Zhongzhi Xing (Hong Kong)") as the company's new auditor.
China Health Technology to Place 143 Million Shares for HK$9 Million
China Health Technology Group (01069) plans to sell a total of up to 143 million shares at a discount of about 13.70% to raise about HK$8.6 million
China Health Technology Group (01069) issued an announcement. On May 28, 2024 (after the trading period), the company...
China Health Technology Group (01069) and Scura signed a strategic cooperation memorandum to jointly develop the R&D and sales business of ginseng extracted ion energy water in China
China Health Technology Group (01069) announced that on May 16, 2024, the company and Fujian Ningdes...
Statutory Earnings May Not Be The Best Way To Understand China Health Technology Group Holding's (HKG:1069) True Position
China Health Technology Group Terminates 52% Stake Acquisition Deal
China Health Technology Group (01069.HK) terminated the acquisition of 52% shares in Liuba Jiashisen Traditional Chinese Medicine Comprehensive Development
Gelonghui, April 8, 丨 China Health Technology Group (01069.HK) announced the acquisition of 52% of the shares in Liuba Jiashisen Traditional Chinese Medicine Comprehensive Development. After signing the share sale agreement, the company then carried out detailed due diligence and other work on the seller. However, at the company's request, the seller failed to provide satisfactory due diligence documentation to the company. Following friendly negotiations between the company and the seller, the contracting parties decided to terminate the acquisition. The Board believes that terminating the agreement will not have any significant adverse impact on the Group's business, operations, or financial position.
CN HEALTH TECH: Interim Report 2023
China Health Technology Returns to Profit in Fiscal H1
China Health Technology Group (01069) announced interim results with net profit of 201 million yuan
China Health Technology Group (01069) announced results for the six months ended December 31, 2023, with revenue of 19...
CN HEALTH TECH: ANNOUNCEMENT OF INTERIM RESULTSFOR THE SIX MONTHS ENDED 31 DECEMBER 2023
China Health Technology (01069.HK) held a board meeting on February 29 to consider and approve the interim results
Gelonghui, Feb. 19 | China Health Technology (01069.HK) announced that it will hold a board meeting on February 29, 2024 (Thursday) to consider and approve the Group's interim results announcement for the six months ended December 31, 2023, and to consider the proposed payment of an interim dividend (if any).
CN HEALTH TECH: DATE OF BOARD MEETING
China Health Technology Group CEO Resigns
China Health Technology Group appoints Wang Yibin as CEO
China Health Technology Group (01069) announced that Chen Weilong has resigned as an executive director and chief executive with effect from January 29, 2024 due to his need for more time to handle other businesses. Wang Yibin has been appointed as CEO with effect from January 29, 2024.
China Health Technology Group (01069) appoints Wang Yibin as CEO
China Health Technology Group (01069) announced that Chen Weilong has resigned as he needs more time to handle other businesses...
China Health Technology Signs Tan Sheep Farming Business Agreement; Shares Rise 6%
No Data